Cargando…
Platelet aggregation inhibitor prescription for newly diagnosed peripheral arterial disease in the Netherlands: a cohort study
OBJECTIVES: Pharmacological treatment of peripheral arterial disease (PAD) comprises of antiplatelet therapy (APT), blood pressure control and cholesterol optimisation. Guidelines provide class-I recommendations on the prescription, but there are little data on the actual prescription practices. Our...
Autores principales: | Brand, Aarent RT, Houben, Eline, Bezemer, Irene D, Visseren, Frank L J, Bots, Michiel L, Herings, Ron MC, de Borst, Gert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818814/ https://www.ncbi.nlm.nih.gov/pubmed/33472782 http://dx.doi.org/10.1136/bmjopen-2020-041715 |
Ejemplares similares
-
Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021) -
Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017) -
Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands
por: Castelijns, Maria C, et al.
Publicado: (2023) -
Opinions on hypertension care and therapy adherence at the healthcare provider and healthcare system level: a qualitative study in the Hague, Netherlands
por: van Grondelle, Saskia E, et al.
Publicado: (2022) -
Platelet-monocyte aggregates: molecular mediators of thromboinflammation
por: Rolling, Christina C., et al.
Publicado: (2023)